The McGovern Center was founded in 2008 as a startup incubator to help develop young Cornell life science companies. The Center is funded by Cornell’s Research Division, the Institute of Biotechnology, NYSTAR and a generous gift from Kevin M. McGovern ’70 and his family.
The Center’s program focuses on accelerating research and development of its client’s companies’ technology and products, validating its client companies’ business plans, and strengthening their management teams. The Center’s goal is to facilitate the forward progress of client companies to the point where each will merit significant outside investment, and achieve self-sufficiency. In doing so, the McGovern Center contributes to the University’s mission as New York State’s Morrill Land Grant institution to support local, regional, and state-wide Life Sciences jobs/economic development.
Dimensional Energy emerges as $20M Carbon X Prize finalist
February 03, 2021
By Blaine Friedlander |February 2, 2021 Dimensional Energy – a Cornell McGovern Center startup company that can capture industrial carbon dioxide and then convert it by way of sunshine into an environmentally friendly products like …
Life after Graduation – a panel discussion from successful CEO graduates of McGovern Center
November 10, 2020
The McGovern Center, a startup incubator located in Weill Hall on Cornell’s Ithaca campus, assists Cornell faculty, staff, students, and outside entrepreneurs in putting together companies based on Life Science technologies, and helps the company …
Global startup summit taps Zymtronix as challenge finalist
February 11, 2020
By Blaine Friedlander | February 11, 2020 Cornell startup Zymtronix – an industrial biotech company serving the pharmaceutical, food, agricultural and chemical industries – has been selected as a challenge finalist at the Hello Tomorrow 2020 …
Nerve-healing startup Renerva joins McGovern incubator
January 12, 2020
By Blaine Friedlander | January 9, 2020 Renerva, a medical startup that is developing an injectable gel to speed the healing of damaged nerves and creating an off-the-shelf nerve-graft product that may spare patients life-long disability, …